Relevant factors for neurologists to define effectiveness of migraine preventive drugs and take decisions on treatment. My‐LIFE European Delphi survey

BACKGROUND: Clinical guidelines agree that preventive treatment should be considered in patients with uncontrolled migraine despite acute medications or patients with ≥4 migraine days per month. However, the criteria to define the effectiveness of treatment and the factors that inform the decision t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pozo‐Rosich, Patricia, Gil‐Gouveia, Raquel, Donnet, Anne, Poole, Anne‐Christine, Gendolla, Astrid, Afridi, Shazia, Sanchez‐De la Rosa, Rainel, Terwindt, Gisela M., Tassorelli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596543/
https://www.ncbi.nlm.nih.gov/pubmed/34173301
http://dx.doi.org/10.1002/ejp.1831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596543/
https://www.ncbi.nlm.nih.gov/pubmed/34173301
http://dx.doi.org/10.1002/ejp.1831

Ejemplares similares